S&P 500 Notches First Close Above 7,100, Nasdaq Posts Longest Win Streak Since 1992: Live Updates

 

 S&P 500 Notches First Close Above 7,100, Nasdaq Posts Longest Win Streak Since 1992: Live Updates

## The 7,102.06 Close That Rewrote Market History

At 4:00 p.m. Eastern Time on April 17, 2026, the S&P 500 did something it had never done before. The index closed above **7,100** for the first time in history, finishing the session at **7,102.06** . The Nasdaq Composite, meanwhile, extended its winning streak to an astonishing **14 consecutive sessions**—its longest run since January 1992, when George H.W. Bush was president and the original "Saved by the Bell" was still on the air .

The Dow Jones Industrial Average joined the celebration, surging **500 points** to close above **50,000** for the first time ever, at approximately **50,018** . The small-cap Russell 2000 also hit a record high, completing a clean sweep of major U.S. indices at all-time highs .

The catalyst was unmistakable. The temporary reopening of the Strait of Hormuz, announced on Thursday morning, sent oil prices plunging and investor sentiment soaring . Brent crude fell below $89 per barrel, while WTI dropped to approximately $83 . The 10-year Treasury yield fell to 4.27 percent, easing pressure on growth stocks .

For the millions of Americans who have watched their 401(k)s recover from the March sell-off, the rally is a relief. For the traders who have been riding the "peace trade," it is validation. And for the market itself, it is a signal that the war-driven volatility may finally be behind us.

This is your live update hub for the historic April 17 market rally. We'll track the major indices, the oil price collapse, the sector rotations, the diplomatic developments, and what comes next as the 10-day ceasefire window begins.

---

## Part 1: The 7,102.06 Milestone – S&P 500 Breaches New Territory

### The Numbers That Matter

The S&P 500's climb above 7,100 was not a momentary spike—it was a decisive close. The index traded as high as 7,108.00 intraday before settling at 7,102.06, a gain of **0.8 percent** .

| **Index** | **Level (April 17)** | **Change** | **Significance** |

| :--- | :--- | :--- | :--- |

| S&P 500 | 7,102.06 | +0.8% | **First close above 7,100** |

| Dow Jones | ~50,018 | +1.0% | **First close above 50,000** |

| Nasdaq Composite | ~24,355 | +1.0% | **14-day winning streak** |

| Russell 2000 | Record high | — | **First record since war began** |

*Source: Yahoo Finance, Reuters, CNBC *

The small-cap Russell 2000 hit its first intraday record high since the U.S.-Iran conflict erupted, joining the major indexes at all-time highs . The CBOE volatility index (VIX) fell to a two-month low of approximately **17.8**, as the prospect of de-escalation encouraged investors to buy risk assets .

### The 14-Day Nasdaq Streak

The Nasdaq Composite's 1.0 percent gain extended its winning streak to **14 consecutive sessions** —its longest since January 1992 . The index has now risen more than 12 percent since its late-March bottom, driven by a combination of AI optimism, falling oil prices, and hopes for a diplomatic resolution to the Iran war.

The technology sector was the biggest boost to the S&P 500, with AI-related and high-growth names leading the charge. Amazon, Microsoft, Nvidia, and Tesla all gained more than 1 percent, while Oracle jumped 3 percent .

---

## Part 2: The Oil Collapse – Brent Plunges Below $89

### The Numbers That Matter

The reopening of the Strait of Hormuz triggered one of the most dramatic oil price drops in recent history. Brent crude fell **more than 10 percent** to approximately $89 per barrel, while WTI tumbled to around $83 .

| **Oil Benchmark** | **Pre-Open Price** | **Post-Announcement** | **Change** |

| :--- | :--- | :--- | :--- |

| Brent Crude | ~$100 | **$89.09** | **-10.3%** |

| WTI Crude | ~$95 | **$81.88** | **-10.2%** |

*Source: Reuters, CNBC *

The decline was supported by reports that the U.S. is considering releasing **$20 billion in frozen Iranian funds** in exchange for the country’s stockpiles of enriched uranium, with further talks expected this weekend . Axios reported that negotiators from the two sides would likely meet for another round of talks.

### The Trump-Blockade Contradiction

Minutes after Iranian Foreign Minister Abbas Araghchi announced the strait was "completely open," President Trump posted on Truth Social that the U.S. Navy’s blockade of Iranian ports "will remain in full force" until a deal is reached to end the conflict . He also said that a deal "should go very quickly in that most of the points are already negotiated," emphasizing it by using all capital letters .

This contradiction—Iran declaring the strait open while the U.S. maintains its blockade—highlights the fragility of the current détente. The strait is open, but Iranian ships are still blockaded. Commercial vessels can transit, but U.S. naval forces remain on high alert.

### The IEA’s Two-Year Warning

Despite the price drop, International Energy Agency Executive Director Fatih Birol warned that it could take **up to two years** to recover a significant share of oil and gas production that has been disrupted . Any recovery would be gradual, Birol said, given the extensive damage to infrastructure in the Persian Gulf region .

---

## Part 3: The Sector Rotations – Winners and Losers in the New Landscape

### The Big Winners: Airlines, Cruises, and Consumer Discretionary

The collapse in oil prices triggered a dramatic rotation out of energy stocks and into the sectors most sensitive to fuel costs.

| **Sector/Stock** | **Performance** | **Driver** |

| :--- | :--- | :--- |

| American Airlines | +7%+ | Lower jet fuel costs |

| United Airlines | +7%+ | Lower jet fuel costs |

| Delta Air Lines | +5%+ | Lower jet fuel costs |

| Carnival Cruise | +8% | Lower fuel costs, travel demand |

| Norwegian Cruise | +8.5% | Lower fuel costs, travel demand |

| Consumer Discretionary | +2% | Improved spending power |

*Source: Yahoo Finance, Reuters *

Airlines and cruise operators were the biggest beneficiaries of the oil price collapse. With jet fuel costs falling sharply, margins for carriers improved overnight. The S&P 500 consumer discretionary sector led gains with a 2 percent rise .

### The Big Losers: Energy Stocks

The S&P 500 energy sector slipped 4.5 percent as oil prices tumbled. Exxon Mobil and Chevron each fell approximately 5 percent and 4 percent, respectively .

| **Energy Stock** | **Decline** |

| :--- | :--- |

| Exxon Mobil (XOM) | -5% |

| Chevron (CVX) | -4% |

| APA Corp | -10.34% |

| Dow Inc | -11.75% |

*Source: The Edge Malaysia, Economic Times *

The declines reflect the market’s assessment that the war premium embedded in energy stocks has largely evaporated. If the ceasefire holds and the Strait remains open, energy stocks could face further pressure.

### The Tech Resilience

The information technology sector was the biggest boost to the S&P 500, with AI-related and high-growth names leading the charge. Amazon, Microsoft, Nvidia, and Tesla all gained more than 1 percent, while Oracle jumped 3 percent .

---

## Part 4: The Diplomatic Landscape – A 10-Day Window

### The Lebanon Ceasefire Connection

The reopening of the Strait of Hormuz was directly tied to the 10-day ceasefire agreed upon by Israel and Lebanon. Araghchi stated that the strait would remain open for the remainder of that truce period .

The ceasefire between Israeli forces and Iran-backed Hezbollah appeared to be holding on Friday, potentially boosting efforts to extend a broader truce involving Iran, the United States, and Israel .

### Trump’s "Deal Close" Declaration

Trump on Thursday said a deal to end hostilities with Iran was close. The two have been negotiating via Pakistan this week amid a ceasefire between them, which is due to end on April 21 .

In a subsequent post, Trump said the U.S. naval blockade on Iranian ships and ports "will remain in full force" until a deal is reached . He also invited Israeli Prime Minister Benjamin Netanyahu and Lebanese President Joseph Aoun to the White House, describing the invitation as the first "substantive" high-level dialogue between the two countries since 1983 .

### The 6-Month Peace Deal Timeline

Some Gulf Arab and European leaders said that a U.S.-Iran peace deal would take about **six months** to be agreed and that the warring sides should extend their ceasefire to cover that timeframe, according to officials .

---

## Part 5: The Earnings Picture – A Mixed Bag

### Netflix’s 10% Plunge

Not all stocks participated in the rally. Netflix slid more than 10 percent after its Q2 guidance missed expectations . The streaming giant’s warning weighed on the communication services sector, though broader market momentum carried the indices higher.

### Truist Financial’s Decline

Truist Financial also traded lower after reporting earnings, reflecting ongoing challenges in the regional banking sector .

### The Big Picture

Despite these individual stock declines, the broader market rally was broad-based. Eight of the 11 S&P 500 sectors traded higher, with technology and consumer discretionary leading the way .

---

## Part 6: The Fed and Inflation – What the Oil Drop Means for Rates

### The Inflation Relief

The sharp drop in oil prices provides immediate relief to inflation expectations. With Brent falling from $100 to $89, the energy component of CPI—which had been running at 12.5 percent year-over-year—will moderate.

For the Federal Reserve, this is welcome news. The central bank has been trapped between fighting inflation and supporting growth. Lower oil prices ease that tension.

### The Rate Cut Calculus

However, analysts caution that one data point does not make a trend. "Oil prices are just one variable," said one strategist. "The Fed will need to see sustained improvement in core inflation before it changes course."

The market is still pricing the first rate cut for September or December, with no move expected at the May meeting.

---

## Part 7: The American Investor’s Playbook – What to Do Now

### The Peace Trade

The market is pricing in a diplomatic resolution. Investors should position accordingly, but remain cautious.

| **Asset Class** | **Action** | **Rationale** |

| :--- | :--- | :--- |

| Energy (XLE) | Reduce | War premium fading |

| Airlines (JETS) | Overweight | Lower fuel costs |

| Technology (XLK) | Overweight | Beneficiary of lower oil |

| Consumer Discretionary (XLY) | Overweight | Improved spending power |

### The Cautious Caveat

The reopening of the Strait is temporary. It is tied to a 10-day ceasefire that could collapse at any moment. Trump’s blockade remains in place. And the underlying geopolitical tensions have not been resolved.

"Nobody in their right mind, and certainly not the administration, trusts anything that Iran says, but actions do matter," said Joseph Trevisani, senior analyst at FXStreet .

Investors should not assume that the rally will continue uninterrupted. The April 21 deadline is approaching, and any breakdown in talks could reverse the gains just as quickly.

---

### FREQUENTLY ASKED QUESTIONS (FAQs)

**Q1: Did the S&P 500 really close above 7,100?**

A: Yes. The S&P 500 closed at **7,102.06** on April 17, 2026, marking the first time the index has ever finished above the 7,100 level .

**Q2: How long has the Nasdaq been rallying?**

A: The Nasdaq Composite has risen for **14 consecutive sessions** —its longest winning streak since January 1992 .

**Q3: Did the Dow close above 50,000?**

A: Yes. The Dow Jones Industrial Average closed above **50,000** for the first time in history, at approximately 50,018 .

**Q4: Why did oil prices drop so sharply?**

A: Iran announced that the Strait of Hormuz is “completely open” for commercial vessels for the remainder of the 10-day Lebanon-Israel ceasefire, easing supply fears .

**Q5: Is the Strait fully open?**

A: Iran says yes. The U.S. says its naval blockade remains in place. The contradiction highlights the fragility of the current détente .

**Q6: How long is the reopening expected to last?**

A: The reopening is tied to the 10-day ceasefire between Israel and Lebanon, which began on April 16. It could be extended if peace talks progress .

**Q7: What is the Nasdaq’s winning streak?**

A: The Nasdaq Composite has risen for 14 consecutive sessions, its longest winning streak since January 1992 .

**Q8: What’s the single biggest takeaway from the April 17 market action?**

A: The S&P 500’s close above 7,100 and the Dow’s breach of 50,000 were driven by the temporary reopening of the Strait of Hormuz. Oil plunged, airlines soared, and the market priced in a diplomatic resolution. But the reopening is fragile, the blockade remains, and the underlying tensions have not been resolved. The rally is real—but so is the risk.

---

## Conclusion: The 7,100 Milestone

On April 17, 2026, the S&P 500 did what it had never done before. The numbers tell the story of a market that is betting on peace:

- **7,102** – The S&P 500’s record close

- **50,018** – The Dow’s first close above 50,000

- **14 days** – The Nasdaq’s winning streak

- **10%** – The drop in oil prices

- **10 days** – The ceasefire window

- **2 years** – The IEA’s estimated recovery timeline

For the investors who held through the March sell-off, the rally is vindication. For the traders who bought the dip, it is profit. For the American family watching gas prices inch down from $4.25, it is hope.

But the reopening is temporary. The blockade remains. And the peace talks could still fail.

The age of assuming the market would stay below 7,100 is over. The age of **watching the ceasefire** has begun.

The 2026 Psychedelic Breakthrough: Why Trump’s Executive Order on LSD and Psilocybin is a Game-Changer for US Health

 

 The 2026 Psychedelic Breakthrough: Why Trump’s Executive Order on LSD and Psilocybin is a Game-Changer for US Health

## The 5,000-Word Guide to the New Era of Mental Health Treatment

At 2:00 p.m. Eastern Time on April 17, 2026, President Donald Trump signed an executive order that will be studied by medical historians for generations. The order, titled “Advancing Breakthrough Therapies for Mental Health and Addiction,” mandates a sweeping re-evaluation of federal policies governing psychedelic substances including psilocybin, MDMA, ibogaine, and LSD .

The directive, signed in the Roosevelt Room with veterans, mental health advocates, and Department of Veterans Affairs officials looking on, gives the Department of Health and Human Services (HHS) and the VA just 90 days to submit a plan to integrate these therapies into clinical practice. The order also instructs the Drug Enforcement Administration (DEA) to review the Schedule I classification of these substances—a designation that has labeled them as having “no accepted medical use” for more than five decades .

For the millions of Americans suffering from treatment-resistant depression, severe PTSD, and opioid addiction, the order offers hope. For the biotech startups that have been developing psychedelic therapies for years, it is a green light. For the investors who have been watching the sector from the sidelines, it is a signal to move.

The market’s response was immediate. The psychedelic biopharma index surged 6.4 percent in intraday trading, with Compass Pathways up 12 percent, MindMed gaining 15 percent, and Atai Life Sciences climbing 9 percent . A new class of “wellness center” licensing applications flooded state health departments within hours of the announcement.

This 5,000-word guide is the definitive analysis of the 2026 psychedelic breakthrough. We’ll examine the executive order’s provisions, the specific substances targeted, the regulatory path forward, the market implications, and what this means for American patients, veterans, and investors.

---

## Part 1: The Executive Order – Breaking Down the Directive

### The 90-Day Clock

The executive order is notable for its specificity and its urgency. The President gave HHS and the VA just 90 days—until mid-July—to submit a comprehensive plan for integrating psychedelic-assisted therapies into clinical practice .

| **Directive** | **Target Agency** | **Deadline** |

| :--- | :--- | :--- |

| Submit plan for psychedelic therapy integration | HHS, VA | 90 days |

| Review Schedule I classification | DEA, HHS | Ongoing |

| Expand VA psychedelic research | DOD, VA | Immediate |

| Establish therapist training standards | SAMHSA | 180 days |

| Create compassionate use pathway | FDA | 60 days |

*Source: White House executive order, April 17, 2026*

The order also directs the Food and Drug Administration (FDA) to establish a “compassionate use” pathway for patients with life-threatening conditions who have exhausted all other treatment options. This provision is modeled on the Right to Try law and is designed to provide immediate relief for the most severe cases while the broader regulatory framework is developed .

### The Veterans Focus

The executive order places particular emphasis on veterans. The Department of Veterans Affairs has been directed to immediately expand its research into psychedelic-assisted therapies for PTSD, depression, and substance use disorders. The VA will also establish a training program for therapists, ensuring that when these treatments become available, there will be qualified professionals to administer them .

“Our veterans have sacrificed too much to be denied the best possible care,” Trump said at the signing ceremony. “For too long, bureaucracy has stood between suffering Americans and life-saving treatments. That ends today” .

---

## Part 2: The Substances – From Schedule I to Breakthrough Therapy

### Psilocybin: Fast-Tracked for Treatment-Resistant Depression

Psilocybin, the active compound in “magic mushrooms,” is the most advanced of the psychedelic therapies. Multiple Phase 3 clinical trials have demonstrated its remarkable efficacy in treating major depressive disorder, particularly in patients who have not responded to traditional antidepressants .

| **Substance** | **2026 Policy Status** | **Primary Target** | **Market Impact** |

| :--- | :--- | :--- | :--- |

| **Psilocybin** | **Fast-Tracked Access** | **TRD (Treatment-Resistant Depression)** | **Surge in “Wellness Center” licensing** |

| **Ibogaine** | **Opioid Pilot Programs** | **Addiction Recovery / PTSD** | **Massive interest from biotech startups** |

| **LSD (Microdose)** | **Research Expansion** | **Cognitive Performance / Anxiety** | **Tech sector and “biohacker” interest** |

| **MDMA** | **FDA Final Review** | **Severe PTSD** | **Expected 2026 wide-scale approval** |

| **DEA Status** | **Review Mandated** | **Schedule I Re-evaluation** | **Possible “Schedule II” move by Q4** |

*Sources: White House EO, FDA briefing documents, DEA scheduling review *

The executive order mandates that HHS submit a plan for “expedited access” to psilocybin for patients with treatment-resistant depression within 60 days. This is expected to take the form of a “breakthrough therapy” designation that allows for wider use outside of clinical trials while the FDA completes its full approval process .

The market impact has been immediate. Applications for “wellness center” licenses—facilities that would administer psychedelic-assisted therapy—have surged in states that have already decriminalized psilocybin, including Oregon and Colorado .

### Ibogaine: The Opioid Crisis Intervention

Ibogaine, a psychoactive substance derived from the African iboga shrub, has shown remarkable promise in treating opioid addiction. Unlike methadone or buprenorphine, which are maintenance therapies, ibogaine has been shown in multiple studies to interrupt addiction with a single or limited number of doses .

The executive order directs HHS to establish pilot programs for ibogaine-assisted therapy for opioid use disorder and PTSD. The programs will be modeled on successful trials conducted in Mexico and Canada, where ibogaine has been used to treat veterans and first responders .

Biotech startups focused on ibogaine have seen massive interest from investors. Atai Life Sciences, which has a dedicated ibogaine program, climbed 9 percent on the day of the announcement .

### LSD: The Microdosing Revolution

Lysergic acid diethylamide (LSD) is perhaps the most controversial of the substances addressed in the executive order. The directive does not authorize widespread access to LSD; rather, it expands research into low-dose (“microdose”) applications for cognitive performance and anxiety .

The order specifically authorizes the National Institute of Mental Health (NIMH) to fund studies on the efficacy of microdosing for anxiety disorders, particularly in high-stress professions such as first responders and military personnel. The tech sector has also taken notice, with several Silicon Valley companies reportedly exploring microdosing programs for employees .

### MDMA: The Final Hurdle

MDMA (3,4-methylenedioxymethamphetamine), commonly known as Ecstasy, is the furthest along in the regulatory process. The FDA is expected to complete its final review of MDMA-assisted therapy for severe PTSD by the end of 2026, with wide-scale approval expected shortly thereafter .

The executive order does not accelerate MDMA’s approval—it is already on a fast track—but it does instruct the VA to prepare for its deployment. The VA has been directed to establish treatment protocols and therapist training programs in anticipation of FDA approval .

---

## Part 3: The DEA Classification – The End of Schedule I?

### The “No Accepted Medical Use” Doctrine

The most significant long-term impact of the executive order may be its directive to the DEA to review the Schedule I classification of psychedelic substances. Schedule I is reserved for drugs with “no accepted medical use” and a “high potential for abuse”—a designation that has been used to justify a blanket prohibition for more than 50 years .

| **Schedule** | **Definition** | **Examples** | **Psychedelic Status** |

| :--- | :--- | :--- | :--- |

| **Schedule I** | No accepted medical use, high abuse potential | Heroin, LSD, psilocybin | **Current status (under review)** |

| **Schedule II** | Accepted medical use, high abuse potential | Cocaine, methamphetamine, oxycodone | **Possible new status for some psychedelics** |

| **Schedule III** | Accepted medical use, moderate abuse potential | Ketamine, Tylenol with codeine | **Likely for MDMA** |

| **Schedule IV** | Accepted medical use, low abuse potential | Xanax, Valium, Ambien | **Possible for psilocybin** |

*Source: DEA scheduling definitions, Controlled Substances Act *

The executive order instructs HHS to conduct a scientific and medical evaluation of psilocybin, MDMA, ibogaine, and LSD, and to provide a recommendation to the DEA on their appropriate scheduling. The review is expected to be completed by the fourth quarter of 2026 .

Most experts expect that MDMA will be rescheduled to Schedule III or IV, allowing it to be prescribed by doctors and dispensed by pharmacies. Psilocybin may follow a similar path, though some experts believe it could remain Schedule II due to its hallucinogenic effects. Ibogaine, with its cardiac risks, may face a more complicated path .

### The “Schedule II” Scenario

The most likely outcome by the end of 2026 is a “Schedule II” designation for psilocybin and LSD. This would recognize their accepted medical use while maintaining some restrictions on prescribing and dispensing. MDMA is expected to be placed in Schedule III or IV .

A Schedule II designation would allow doctors to prescribe these substances, but patients would need to obtain them from specialized pharmacies. It would also remove the most significant barrier to research: the onerous registration requirements that currently apply to Schedule I substances .

---

## Part 4: The Regulatory Path – From Executive Order to Patient Access

### The FDA’s Role

The FDA has already designated psilocybin and MDMA as “breakthrough therapies,” a status that expedites their review and approval. The executive order does not change the FDA’s statutory authority, but it does signal that the administration will not stand in the way of approval .

The FDA is expected to complete its review of MDMA-assisted therapy for PTSD by the end of 2026. Psilocybin for treatment-resistant depression is likely to follow in 2027. Ibogaine and LSD are further behind, with approval not expected before 2028 .

### The State Role

While the federal government sets the framework, states will play a critical role in implementation. Oregon has already legalized psilocybin-assisted therapy through its Measure 109, and Colorado has decriminalized psilocybin. Other states, including California, New York, and Massachusetts, are considering similar measures .

The executive order encourages states to develop their own regulatory frameworks, with the promise of federal funding for training and infrastructure. This “cooperative federalism” approach is designed to accelerate access while allowing states to tailor programs to local needs .

### The Therapist Training Pipeline

One of the most significant barriers to widespread access is the lack of trained therapists. The executive order directs the Substance Abuse and Mental Health Services Administration (SAMHSA) to develop training standards for psychedelic-assisted therapy within 180 days .

The training will cover:

- Patient screening and preparation

- Dosing and administration

- Managing challenging experiences

- Integration therapy

- Safety protocols

Several universities, including Johns Hopkins, NYU, and Imperial College London, have already established psychedelic research centers and are poised to offer training programs once federal standards are set .

---

## Part 5: The Market Impact – Biotech’s New Frontier

### The 6.4% Surge

The biopharma sector’s reaction to the executive order was immediate and dramatic. The psychedelic biopharma index surged 6.4 percent in intraday trading, with individual companies posting even larger gains .

| **Company** | **Ticker** | **Daily Gain** | **Focus** |

| :--- | :--- | :--- | :--- |

| Compass Pathways | CMPS | +12% | Psilocybin for TRD |

| MindMed | MNMD | +15% | LSD microdosing |

| Atai Life Sciences | ATAI | +9% | Ibogaine, psilocybin |

| GH Research | GHRS | +8% | 5-MeO-DMT |

| Cybin | CYBN | +11% | Psilocycin analogs |

*Source: Market data, April 17, 2026*

The gains reflect investor confidence that the executive order will accelerate regulatory approval and expand the addressable market. Compass Pathways, which has the most advanced psilocybin program, saw its stock hit a 52-week high .

### The “Neuro-Innovation” Pivot

The executive order has triggered a broader sector rotation, with investors pivoting from artificial intelligence and biotech’s traditional “oncology-first” focus toward what analysts are calling “neuro-innovation” .

Venture capital firms that had been focused on AI and SaaS are now establishing dedicated psychedelic funds. The “biohacker” community, which has long advocated for microdosing, is also taking notice, with several startups developing standardized microdose products .

### The Wellness Center Boom

The most immediate market impact has been in the “wellness center” space. Applications for licenses to operate psychedelic-assisted therapy centers have surged in states with existing decriminalization laws. Real estate investors are also taking note, with properties in Oregon and Colorado seeing increased interest from potential clinic operators .

---

## Part 6: The Clinical Evidence – Why This Is Not Pseudoscience

### The Psilocybin Data

The clinical evidence for psilocybin’s efficacy in treating depression is robust. A 2024 meta-analysis of 12 clinical trials involving more than 800 patients found that psilocybin-assisted therapy produced a **response rate of 65%** and a **remission rate of 55%** in patients with treatment-resistant depression—rates that far exceed those achieved by traditional antidepressants .

The durability of the response is also notable. In long-term follow-up studies, many patients maintained improvement for six months or longer after just two or three dosing sessions .

### The MDMA Data

MDMA-assisted therapy for PTSD has an even stronger evidence base. A Phase 3 trial published in *Nature Medicine* in 2025 found that **71% of patients no longer met the diagnostic criteria for PTSD** after three MDMA-assisted therapy sessions, compared to 28% in the placebo group .

The FDA has designated MDMA-assisted therapy as a “breakthrough therapy,” and the drug is expected to receive full approval by the end of 2026 .

### The Ibogaine Promise

The evidence for ibogaine is less robust but still promising. A 2025 study of 30 veterans with traumatic brain injury and PTSD found that a single ibogaine dose produced “significant and sustained reductions” in PTSD symptoms and cognitive impairment .

The study’s authors noted that the effects were still present at the 12-month follow-up, suggesting that ibogaine may produce lasting changes in brain function .

---

## Part 7: The American Patient’s Playbook – What to Do Now

### If You Suffer from Treatment-Resistant Depression

If you have tried multiple antidepressants without success, you may be a candidate for psilocybin-assisted therapy once it becomes available. The executive order’s “compassionate use” pathway may allow access before full FDA approval for patients with life-threatening conditions .

Talk to your doctor about whether you might qualify for a clinical trial. Clinicaltrials.gov lists several ongoing psilocybin trials for treatment-resistant depression .

### If You Are a Veteran with PTSD

The VA has been directed to expand its psychedelic research programs. Veterans who are interested in participating should contact their local VA medical center and ask about opportunities in psychedelic-assisted therapy trials .

The VA’s “Breakthrough Therapies” program is specifically designed to provide access to investigational treatments for veterans with severe, treatment-resistant conditions .

### If You Are an Investor

The psychedelic biotech sector is still in its early stages, and volatility will be high. Investors should focus on companies with strong clinical data, robust patent protection, and experienced management teams .

The sector is likely to see significant consolidation over the next 12-18 months as larger pharmaceutical companies acquire successful psychedelic startups .

---

### FREQUENTLY ASKED QUESTIONS (FAQs)

**Q1: What substances does the executive order cover?**

A: The order specifically addresses psilocybin, MDMA, ibogaine, and LSD, but it also instructs HHS to review other psychedelic substances for potential therapeutic use .

**Q2: Does this mean psychedelics are now legal?**

A: No. The executive order does not legalize psychedelics. It directs federal agencies to expedite research and develop regulatory pathways for their medical use. Recreational use remains illegal .

**Q3: How long will it take for these therapies to become available?**

A: MDMA-assisted therapy for PTSD is expected to receive FDA approval by the end of 2026. Psilocybin for treatment-resistant depression is likely to follow in 2027. Ibogaine and LSD are further behind .

**Q4: Will insurance cover these treatments?**

A: The executive order does not address insurance coverage. However, the VA has been directed to provide access to veterans, and private insurers are likely to follow once FDA approval is granted .

**Q5: What is the DEA’s role?**

A: The DEA has been instructed to review the Schedule I classification of psychedelic substances. A change in scheduling would remove the most significant regulatory barrier to research and clinical use .

**Q6: Are these treatments safe?**

A: When administered in controlled clinical settings with trained therapists, psychedelic-assisted therapy has a strong safety profile. However, these substances can cause significant psychological distress in some individuals and are not without risks .

**Q7: What is “microdosing”?**

A: Microdosing involves taking very small, sub-perceptual doses of psychedelic substances—typically one-tenth to one-twentieth of a standard dose. The executive order authorizes research into microdosing for cognitive performance and anxiety .

**Q8: What’s the single biggest takeaway from the executive order?**

A: The federal government has officially recognized that psychedelic substances have legitimate medical uses. After 50 years of prohibition, the war on psychedelics is ending—and a new era of mental health treatment is beginning.

---

## Conclusion: The Psychedelic Renaissance

On April 17, 2026, President Trump signed an executive order that will be remembered as the beginning of the psychedelic renaissance in American medicine. The numbers tell the story of a paradigm shift:

- **6.4%** – The biopharma index surge

- **90 days** – The deadline for the HHS/VA plan

- **71%** – MDMA’s PTSD remission rate in clinical trials

- **65%** – Psilocybin’s depression response rate

- **50 years** – The duration of the Schedule I prohibition now under review

- **2026** – The year MDMA is expected to receive FDA approval

For the veterans who have waited decades for effective PTSD treatment, the order offers hope. For the patients with treatment-resistant depression who have tried every antidepressant without success, it offers an alternative. For the biotech startups that have been developing these therapies for years, it offers a path to market.

The psychedelic renaissance is not about dropping acid at a rock concert. It is about healing. It is about science. And it is about time.

The age of prohibition is ending. The age of **evidence-based psychedelic medicine** has begun.

The End of Charging? Why NIO’s 3-Minute Battery Swap Just Hit 100 Million Services and What it Means for the 2026 EV Market

 

 The End of Charging? Why NIO’s 3-Minute Battery Swap Just Hit 100 Million Services and What it Means for the 2026 EV Market

## The 100 Million Milestone That Just Rewrote EV History

At 10:00 a.m. Beijing time on April 18, 2026, NIO achieved a milestone that will be studied by automakers for years. The Chinese electric vehicle manufacturer announced that its battery-swapping network had surpassed **100 million cumulative swaps** since the first station opened in May 2018 .

The 100 millionth swap was completed at the Shanghai Sijing Swap Station, with a NIO ET7 owner named Lu Ning having the honor of making history . The company marked the occasion with a special ceremony, celebrating a decade of building what is now the world’s largest battery-swapping network.

This milestone comes at a pivotal moment for the EV industry. The Iran war has sent electricity prices soaring in many markets, battery原材料 costs remain elevated, and consumers are increasingly anxious about both range and residual value. NIO’s bet on swapping—which it has pursued alongside conventional charging—is suddenly looking prescient.

The numbers tell the story of a technology that has gone from niche experiment to mass-market reality. NIO’s **fifth-generation swap station (Power Swap 5.0)** , currently being rolled out, can complete a battery swap in **less than 3 minutes** —faster than filling a gas tank . Each station can handle up to **408 swaps per day** , a dramatic increase from the 72 swaps per day of the first-generation stations .

For American EV buyers who have become accustomed to waiting 20 to 45 minutes at a DC fast charger, these numbers are almost unbelievable. But in China, battery swapping is rapidly becoming the preferred method of replenishing energy for a growing segment of EV owners.

This 5,000-word guide is the definitive analysis of NIO’s 100 million swap milestone, the technology behind it, and what it means for the future of the global EV market.

---

## Part 1: The 100 Million Milestone – Breaking Down the Numbers

### The Journey to 100 Million

NIO launched its first battery swap station in May 2018, in Shenzhen’s Nanshan District . At the time, the concept was met with skepticism. Critics argued that swapping was too complex, too expensive, and unnecessary in a world of improving fast-charging technology.

Seven years later, the skeptics have been silenced.

| **Milestone** | **Date Achieved** | **Time Between Milestones** |

| :--- | :--- | :--- |

| 1 million swaps | July 2021 | ~3 years |

| 10 million swaps | December 2022 | ~1.5 years |

| 50 million swaps | August 2024 | ~1.5 years |

| **100 million swaps** | **April 18, 2026** | **~1.5 years** |

*Source: CarNewsChina, NIO official announcements*

The acceleration is remarkable. The first million swaps took three years; the most recent 50 million took just 20 months. This exponential growth reflects both the expansion of NIO’s network and the increasing adoption of swapping by NIO vehicle owners.

### The 100 Millionth Swap Ceremony

NIO celebrated the milestone with a ceremony at the Shanghai Sijing Swap Station. The lucky owner, Lu Ning, received a special gift from the company, including a year of free battery swaps .

William Li, NIO’s founder and CEO, took to the NIO app to thank owners: “100 million swaps is not just a number; it is the trust of 100 million times from users. Thank you to every user who chooses NIO and chooses battery swapping” .

---

## Part 2: The Technology – Power Swap 5.0

### The Numbers That Matter

NIO’s latest swap station, the **Power Swap 5.0**, represents a significant leap forward in speed, capacity, and compatibility. The station began internal testing in late March 2026 and is now being rolled out to select locations .

| **Metric** | **NIO Power Swap 5.0** | **Conventional DC Fast Charge** |

| :--- | :--- | :--- |

| **Service Time** | **< 3 Minutes** | **20–45 Minutes** (to 80%)  |

| **Cumulative Swaps** | **100 Million+** | N/A |

| **Station Capacity** | **Up to 408 swaps/day** | **20–40 sessions/day** (per charger) |

| **Grid Impact** | **Grid-Friendly (V2G)** | **High-Peak Demand Stress** |

| **Battery Health** | **Managed & Inspected** | Variable (Fast-charge degradation) |

| **Compatibility** | **Broad (Multiple Brands)** | Model-Specific (NACS/CCS) |

*Sources: NIO, Blink Charging, ITDP *

### Speed: The 3-Minute Advantage

The most obvious advantage of swapping is speed. A NIO Power Swap 5.0 station can complete a full battery replacement in **less than 3 minutes** . This is faster than filling a gas tank and dramatically faster than even the most advanced DC fast chargers, which typically take 20 to 45 minutes to reach 80 percent charge .

For drivers in a hurry, this is a game-changer. The difference between a 3-minute stop and a 30-minute stop is the difference between a quick errand and a planned break.

### Station Capacity: 408 Swaps Per Day

The Power Swap 5.0 station can handle up to **408 swaps per day** , a dramatic increase from the 72 swaps per day of first-generation stations . This high throughput is achieved through automated systems that minimize downtime between swaps.

By contrast, a typical DC fast charger can handle 20 to 40 sessions per day, depending on battery sizes and charging speeds. The swap station’s higher throughput means it can serve more customers with less land and fewer connection points.

### Grid Impact: The V2G Advantage

One of the most overlooked advantages of battery swapping is its impact on the electrical grid. DC fast chargers draw massive amounts of power during peak demand periods, straining local grids and often requiring expensive infrastructure upgrades .

NIO’s swap stations, by contrast, can be designed with **vehicle-to-grid (V2G) capabilities** . They can charge swapped batteries during off-peak hours when electricity is cheaper and greener, then use stored power to charge the next battery. This “grid-friendly” approach reduces peak demand stress and can even provide stability services to utilities.

### Battery Health: The Inspection Advantage

Battery degradation is one of the biggest concerns for EV buyers. Fast charging, in particular, can accelerate battery wear, especially when done frequently .

NIO’s swap stations automatically inspect every battery that enters the system. If a battery shows signs of degradation, it is removed from circulation and sent for maintenance or recycling. This ensures that NIO owners always receive a battery in good health—a guarantee that no plug-in charger can offer.

### Compatibility: The Multi-Brand Future

The Power Swap 5.0 station is designed to be **broadly compatible** with multiple brands. NIO has announced that the new stations will support swapping for its sub-brands, including **Onvo (formerly Alps) and Firefly** .

More significantly, NIO has been in talks with other automakers about adopting its swap standard. The company signed a battery-swapping cooperation agreement with Geely in 2024, and it has held discussions with several European manufacturers. If NIO’s standard becomes widely adopted, swap stations could become as common as gas stations—and just as brand-agnostic.

---

## Part 3: The Competitive Landscape – Swapping vs. Charging

### The Limitations of Fast Charging

DC fast charging has improved dramatically over the past decade. Modern chargers can deliver 150 to 350 kW, and some are now reaching into the megawatt range for commercial vehicles . But even the best chargers have inherent limitations:

1. **Time**: Even the fastest chargers take 20-45 minutes to reach 80 percent .

2. **Battery degradation**: Frequent fast charging accelerates battery wear .

3. **Grid strain**: High-power chargers draw massive peak loads, requiring expensive infrastructure.

4. **Charger availability**: Even with network growth, finding an available fast charger can be challenging during peak travel times.

5. **Cold weather**: Charging speeds drop significantly in cold temperatures.

### The Advantages of Swapping

Battery swapping addresses many of these limitations:

1. **Speed**: Under 3 minutes is faster than filling a gas tank.

2. **Battery health**: Centralized charging and inspection ensure battery quality.

3. **Grid optimization**: Swapping stations can charge batteries during off-peak hours.

4. **Predictability**: Swap times are consistent regardless of weather or battery state.

5. **Lower upfront cost**: Swapping enables “battery-as-a-service” models, reducing vehicle purchase price.

### The Disadvantages of Swapping

Swapping is not without its challenges:

1. **Infrastructure cost**: Swap stations are more expensive to build than chargers.

2. **Standardization**: Without industry-wide standards, swapping is limited to compatible vehicles.

3. **Inventory management**: Stations must maintain adequate battery inventory to meet demand.

4. **Battery ownership**: The battery-as-a-service model requires complex financial arrangements.

---

## Part 4: The Battery-as-a-Service Model – NIO’s Secret Weapon

### What Is BaaS?

NIO’s battery-swapping network is inseparable from its **Battery-as-a-Service (BaaS)** business model. Under BaaS, customers purchase the vehicle but lease the battery. The monthly lease fee includes access to unlimited battery swaps.

| **BaaS Feature** | **Benefit** |

| :--- | :--- |

| Lower purchase price | Vehicle price reduced by battery cost (~$10,000) |

| Battery upgrades | Access to newer battery technology over time |

| No degradation worry | Batteries are managed by NIO |

| Unlimited swaps | No per-swap fee (included in subscription) |

This model addresses two of the biggest consumer concerns about EVs: high upfront cost and battery degradation. By separating the battery from the vehicle, NIO makes its cars more affordable and eliminates range anxiety—because a depleted battery can simply be swapped for a full one.

### The Financial Impact

BaaS has been a key driver of NIO’s success. The lower upfront cost makes NIO vehicles competitive with internal combustion engine cars, even before considering fuel savings. And the predictable monthly fee appeals to budget-conscious consumers.

For NIO, BaaS creates recurring revenue and customer lock-in. Owners who lease their batteries are unlikely to switch to a competitor that doesn’t offer a similar service.

---

## Part 5: The Global Expansion – Is Swapping Coming to America?

### NIO’s International Ambitions

NIO has been expanding beyond China. The company entered Europe in 2021 and now operates swap stations in Norway, Germany, the Netherlands, Sweden, and Denmark . In January 2026, NIO announced plans to expand to the Middle East and North Africa, with a launch in the UAE planned for late 2026 .

| **Region** | **Swap Stations** | **Status** |

| :--- | :--- | :--- |

| China | 2,000+ | Operational |

| Europe | 50+ | Operational |

| Middle East | Planned | Launching 2026 |

The United States remains a notable absence from NIO’s map. The company has faced regulatory and trade barriers that have prevented it from entering the U.S. market. But as swapping technology matures and proves its value, pressure may build for American adoption—whether through NIO or domestic manufacturers.

### The Tesla Factor

Tesla has famously rejected battery swapping. Elon Musk demonstrated a swap in 2013 but abandoned the idea, citing low consumer demand and the high cost of infrastructure. Instead, Tesla doubled down on Superchargers, which remain the gold standard for fast charging.

But the calculus may be changing. Tesla’s Supercharger network, while excellent, still requires 20-40 minute stops. And as Tesla scales its Semi and Cybertruck—vehicles with enormous batteries—the limitations of charging become more acute. If swapping proves successful for commercial fleets, Tesla may need to reconsider.

### The Chinese Competitors

NIO is not alone in pursuing swapping. Geely, through its CaoCao Mobility subsidiary, has been testing swap stations for its ride-hailing fleet. BAIC has also deployed swap stations for taxis. And a handful of startups are developing swap technology for two-wheelers and light commercial vehicles.

If swapping becomes the standard in China—the world’s largest EV market—it will be difficult for global manufacturers to ignore.

---

## Part 6: The Consumer Perspective – What This Means for American EV Buyers

### The “Range Anxiety” Solution

The single biggest barrier to EV adoption is range anxiety—the fear of running out of charge before reaching a destination. Fast charging has reduced this anxiety but not eliminated it. A 30-minute stop is still a significant inconvenience.

Swapping eliminates range anxiety entirely. A 3-minute stop is no more disruptive than a gas station visit. If swapping networks become widespread, the psychological barrier to EV adoption could finally disappear.

### The Residual Value Problem

Another major concern for EV buyers is residual value. Batteries degrade over time, and a used EV with an old battery is worth significantly less than one with a new battery.

BaaS solves this problem. Because the battery is leased, the vehicle’s residual value is not affected by battery degradation. This makes NIO vehicles more attractive to used-car buyers and could lead to stronger resale values.

### The Charging vs. Swapping Decision

For American EV buyers today, swapping is not an option. But as the technology matures and (hopefully) expands to the U.S., consumers will face a choice: buy a vehicle that charges or one that swaps.

| **Factor** | **Charging** | **Swapping** |

| :--- | :--- | :--- |

| Refueling time | 20-45 minutes | <3 minutes |

| Upfront cost | Lower | Lower (with BaaS) |

| Home charging | Yes | No (home swap not possible) |

| Infrastructure | Extensive | Limited |

| Battery ownership | Owned | Leased |

For drivers who can charge at home, swapping may offer little advantage. For those without home charging—apartment dwellers, for example—swapping could be transformative.

---

## Part 7: The American Investor’s Playbook – What to Watch

### The NIO Stock Trade

NIO’s 100 million swap milestone is a significant achievement, but investors should be cautious. The company faces intense competition in China, regulatory barriers in the U.S., and ongoing profitability concerns.

| **Factor** | **Bull Case** | **Bear Case** |

| :--- | :--- | :--- |

| Technology | Swapping is superior for urban users | Charging is improving rapidly |

| China market | Strong brand, loyal customers | Fierce competition from BYD, Tesla |

| International expansion | Europe and Middle East growth | U.S. market remains closed |

| Profitability | BaaS creates recurring revenue | High infrastructure costs |

### The Supply Chain Angle

The companies that build swap stations and their components could benefit from the technology’s growth, regardless of which automaker succeeds. Investors should watch:

- **Automation suppliers**: Companies that provide robotics and automation for swap stations.

- **Battery manufacturers**: Swapping increases battery utilization, potentially benefiting producers.

- **Grid infrastructure**: V2G-enabled swap stations require smart grid technology.

### The Regulatory Watch

The biggest question for American investors is whether swapping will ever come to the United States. NIO has not announced plans, and trade tensions make entry difficult. But if domestic manufacturers adopt swapping—or if a startup emerges with a competing standard—the landscape could change quickly.

---

### FREQUENTLY ASKED QUESTIONS (FAQs)

**Q1: How many battery swaps has NIO completed?**

A: As of April 18, 2026, NIO has completed **100 million battery swaps** since its first station opened in May 2018 .

**Q2: How fast is NIO’s latest swap station?**

A: NIO’s Power Swap 5.0 can complete a battery swap in **less than 3 minutes** , compared to 20-45 minutes for a DC fast charge to 80 percent .

**Q3: How many swaps can a Power Swap 5.0 station handle per day?**

A: Each station can handle up to **408 swaps per day** , dramatically improving throughput over earlier generations.

**Q4: What is Battery-as-a-Service (BaaS)?**

A: BaaS is NIO’s model where customers lease the battery rather than purchasing it outright. The monthly fee includes unlimited battery swaps and ensures the battery is always in good health.

**Q5: Is battery swapping available in the United States?**

A: Not yet. NIO has not entered the U.S. market due to regulatory and trade barriers. However, the technology could be adopted by domestic manufacturers in the future.

**Q6: Is swapping better than fast charging?**

A: Swapping is faster and gentler on batteries, but requires specialized infrastructure and standardization. Fast charging is more widely available and allows home charging. The best solution may be a combination of both.

**Q7: What vehicles can use NIO’s swap stations?**

A: Currently, all NIO-brand vehicles, as well as vehicles from its sub-brands Onvo and Firefly, are compatible. NIO has also signed cooperation agreements with other manufacturers, including Geely .

**Q8: What’s the single biggest takeaway from NIO’s 100 million swap milestone?**

A: Battery swapping has moved from a niche experiment to a proven, scalable technology. The 100 millionth swap proves that drivers will use swapping when it is fast, convenient, and affordable. For the EV industry, the question is no longer whether swapping works—it is whether the rest of the world will follow China’s lead.

---

## Conclusion: The 100 Million Vote of Confidence

On April 18, 2026, NIO achieved a milestone that validates a decade of investment in a technology that many dismissed as impractical. The numbers tell the story of a system that has proven itself at scale:

- **100 million swaps** – A testament to consumer adoption

- **<3 minutes** – Faster than filling a gas tank

- **408 swaps/day** – Unprecedented station throughput

- **V2G capability** – Grid-friendly, not grid-straining

- **Multi-brand compatibility** – The path to industry-wide adoption

For the drivers in China who have made swapping their preferred refueling method, the milestone is a validation of their choice. For the automakers who have watched from the sidelines, it is a signal that swapping is real. For the American EV industry, it is a challenge: will we embrace swapping, or will we be left behind?

The age of waiting 30 minutes at a charger is ending. The age of **3-minute battery swaps** has begun—at least in China. The question is how long the rest of the world will take to catch up.

White House Chief of Staff Meets with Anthropic CEO Over Its New AI Technology: The Mythos Summit That Just Changed the Game

 

 White House Chief of Staff Meets with Anthropic CEO Over Its New AI Technology: The Mythos Summit That Just Changed the Game

## The 5,000-Word Guide to the White House-Anthropic "Peace Summit"

At 11:00 a.m. Eastern Time on April 17, 2026, a black SUV pulled up to the West Wing entrance of the White House. Out stepped Dario Amodei, the CEO of Anthropic, the artificial intelligence company that had been publicly branded a "radical left, woke company" by President Trump just two months earlier . He was there to meet with White House Chief of Staff Susie Wiles and Treasury Secretary Scott Bessent .

The meeting, described by both sides as **"productive and constructive,"** marks a dramatic reversal in the relationship between the U.S. government and one of the world's most important AI firms . It comes just 10 days after Anthropic unveiled its latest model, **Claude Mythos Preview**, which the company itself has deemed too dangerous for public release due to its unprecedented ability to find and exploit cybersecurity vulnerabilities .

For months, the Trump administration and Anthropic had been locked in a bitter legal and political battle. The Pentagon had labeled Anthropic a **"supply chain risk"** —a designation typically reserved for foreign adversaries—after the company refused to grant the military unrestricted access to its AI models for uses including autonomous weapons and mass domestic surveillance . President Trump had ordered all federal agencies to stop using Anthropic's technology, declaring on Truth Social that the company had made a "DISASTROUS MISTAKE" .

Now, the calculus has changed. Mythos is too powerful to ignore. And as one source close to the negotiations told Axios, **"If the US government abandons this new model, it would be giving China a huge gift"** .

This 5,000-word guide is the definitive breakdown of the White House-Anthropic summit, the Mythos model at the center of the controversy, the "Project Glasswing" initiative, and what this means for the future of AI, national security, and the global technology race.

---

## Part 1: The Summit – From "Radical Left" to "Productive and Constructive"

### The Players in the Room

The meeting was not a low-level staff briefing. It was a direct engagement between Anthropic's top leadership and the highest echelons of the Trump administration.

| **Attendee** | **Title** | **Role** |

| :--- | :--- | :--- |

| Dario Amodei | CEO, Anthropic | Lead negotiator for the AI firm |

| Susie Wiles | White House Chief of Staff | The "gatekeeper" of the West Wing |

| Scott Bessent | Treasury Secretary | Overseeing financial system vulnerabilities |

The meeting was first reported by Axios and later confirmed by the BBC, Reuters, and multiple other outlets . It was described by a Trump advisor as the moment when the "circus" surrounding the Pentagon dispute was finally elevated to the highest level for resolution .

### The Shift in Tone

The White House's official statement was carefully worded but unmistakably positive: "We discussed opportunities for collaboration, as well as shared approaches and protocols to address the challenges associated with scaling this technology. The conversation also explored the balance between advancing innovation and ensuring safety" .

Anthropic echoed the sentiment, saying the meeting was "productive" and focused on "key shared priorities such as cybersecurity, America's lead in the AI race, and AI safety" .

This marks a 180-degree turn from February 27, when Trump issued a social media directive ordering all federal agencies to immediately stop using Anthropic's products . At the time, the President had declared: "We will not do business with them again!" .

### The Treasury Secretary’s Presence

The presence of Treasury Secretary Scott Bessent was particularly telling. According to sources familiar with his thinking, Bessent attended because he "wants to make sure everyone is on the same page" .

His concern is the financial system. Mythos has the capability to identify vulnerabilities in legacy banking infrastructure—systems that integrate cutting-edge tools with decades-old software . If those vulnerabilities were exploited, the consequences could be catastrophic. Government officials in at least three countries—the U.S., Canada, and Britain—have already met with top banking officials to discuss the threats posed by Mythos .

---

## Part 2: The Model – Why Mythos Is Too Dangerous to Release

### The 73% Hacking Success Rate

Announced on April 7, 2026, Claude Mythos Preview represents what Anthropic calls a "step change" in AI capability . The model is designed to operate like a senior software engineer, capable of spotting subtle bugs, self-correcting mistakes, and—most alarmingly—autonomously finding and exploiting cybersecurity vulnerabilities.

| **Capability Metric** | **Performance** |

| :--- | :--- |

| Expert-level hacking tasks | **73% success rate** (UK AISI test) |

| Prior AI performance | 0% (before April 2025) |

| Mathematical Olympiad (USAMO) | +31 pts vs. Opus 4.6 |

| Vulnerabilities found | All major OS and browsers |

| Patched rate | <1% |

Independent evaluations by the U.K.'s AI Security Institute (AISI), which was granted early access, found that the model succeeded in expert-level hacking tasks 73 percent of the time . Prior to April 2025, no AI model could complete those tasks at all.

The model identified critical faults in every widely used operating system and web browser. Of those vulnerabilities, **99 percent have not yet been patched** . And Anthropic has disclosed only a fraction of what it says it has found.

### The "Step Change" vs. "More of the Same" Debate

The cybersecurity community remains divided on the true severity of the threat.

Ciaran Martin, former CEO of the U.K.'s National Cyber Security Center, told Yahoo News: "It's a big deal, but it's unlikely to prove to be the end of the world. I would not be at the more apocalyptic end of the scale" .

Peter Swire, a professor at Georgia Tech's School of Cybersecurity and Privacy and a former advisor to the Clinton and Obama administrations, added: "A large fraction of the cybersecurity professors believe this is pretty much what was expected, and pretty much more of the same" .

But even the skeptics acknowledge that Mythos is a significant advance. The model's ability to turn a known vulnerability into a working exploit—a process called "weaponization"—is what has the financial industry on edge.

### The AISI Caveat

The U.K. AI Security Institute noted an important limitation: during testing, Mythos faced "near-nonexistent software defenses" that lacked many protections present in the real world . Martin compared this to a soccer forward scoring a goal against the world's worst goalkeeper.

However, the institute also warned that "Mythos Preview can exploit systems with weak security posture, and it is likely that more models with these capabilities will be developed" .

### The "China Gift" Argument

The most compelling argument for the administration to reconcile with Anthropic came from a source familiar with the negotiations, who told Axios: "If the U.S. government gives up on this new model, it would be giving a huge gift to China" .

The Wall Street Journal published a similar editorial in February, warning that Trump's "extreme and unnecessary violent suppression" of Anthropic was a "self-destructive display" that would cause China to "rejoice" .

The logic is simple: Anthropic is an American company with American technology. If the U.S. government refuses to use it, China will not hesitate to develop its own equivalent—and use it aggressively.

---

## Part 3: Project Glasswing – The $100 Million Defensive Coalition

### The 12-Tech Giant Partnership

On the same day Mythos was announced, Anthropic launched **Project Glasswing**, a defensive coalition of 12 tech and financial giants . The initiative includes Amazon, Apple, Google, Microsoft, Nvidia, JPMorgan Chase, CrowdStrike, and Palo Alto Networks.

| **Project Glasswing Partner** | **Role** |

| :--- | :--- |

| Amazon, Google, Microsoft, Nvidia | Cloud & AI Infrastructure |

| Apple | Hardware & Security |

| JPMorgan Chase | Financial System Defense |

| CrowdStrike, Palo Alto Networks | Cybersecurity Platforms |

The coalition has two goals. First, to use restricted access to Mythos to find and fix vulnerabilities in critical software before attackers can exploit them. Second, to establish protocols for the safe deployment of advanced AI models.

### The "Defensive Only" Restriction

Access to Mythos is extremely limited. Anthropic has made the model available only to a select group of partners under strict "defensive use only" terms . Organizations cannot use Mythos for offensive cyber operations or to test third-party systems without authorization.

Anthropic co-founder and policy chief Jack Clark explained the rationale at the Semafor World Economy conference this week: "We're releasing it to a subset of some of the world's most important companies and organizations so they can use this to find vulnerabilities" .

He added that Mythos, while ahead of the curve, is not a "special model" that will remain unique for long. "There will be other systems just like this in a few months from other companies, and in a year to a year-and-a-half later, there will be open-weight models from China that have these capabilities" .

### The Government Interest

U.S. intelligence agencies and the Cybersecurity and Infrastructure Security Agency (CISA) are already testing Mythos . According to U.S. officials, "almost every agency" except the Defense Department wants to use Anthropic's products .

The Treasury Department, where Bessent presides, is particularly interested in using Mythos to protect the financial system.

---

## Part 4: The Legal Battle – The Pentagon vs. Anthropic

### The "Supply Chain Risk" Designation

The dispute that led to the White House meeting began with a fundamental disagreement over how Anthropic's AI should be used . During negotiations over a $200 million contract, Anthropic sought assurances that its technology would not be used for fully autonomous weapons or mass domestic surveillance .

The Pentagon refused to accept those restrictions. Then-Defense Secretary Pete Hegseth declared that no private contractor could tell the military how to use its technology—that the military must be allowed to use AI for "all lawful purposes" .

When Anthropic held its ground, the Pentagon responded with an unprecedented move: it labeled Anthropic a **"supply chain risk,"** a designation previously reserved for foreign adversaries like China's Huawei . The label sharply limited the use of Anthropic's technology across the federal government.

### Trump’s "Disastrous Mistake" Post

President Trump escalated the conflict on February 27, posting on Truth Social that "The Leftwing nut jobs at Anthropic have made a DISASTROUS MISTAKE trying to STRONG-ARM the Department of War" . He ordered all federal agencies to stop using Anthropic's products immediately.

The post sent shockwaves through the tech industry. It was the first time a sitting president had publicly attacked a major American AI company.

### The Legal Challenges

Anthropic responded by filing lawsuits in two federal courts . The company argued that the "supply chain risk" designation was retaliation for its refusal to remove safety guardrails—a violation of its First Amendment and due process rights .

In late March, a judge in the U.S. District Court for the Northern District of California temporarily stopped the Pentagon from enforcing the designation . However, on April 8, a separate ruling in the D.C. Circuit Court of Appeals denied Anthropic's request to block the label entirely . The legal battle remains unresolved.

### The Pentagon’s Dilemma

Despite the public conflict, engineers at the Pentagon are petitioning to keep using Anthropic's technology . The older version of Claude currently running on Pentagon systems is used to analyze intelligence and handle sensitive data. Engineers have urged the department to update to the newest models, but because the models are held on systems housed within the Pentagon, Anthropic cannot update them without access.

Senior Pentagon officials declined to comment on the dispute, citing the ongoing lawsuits. Meanwhile, other agencies are moving forward with alternative AI providers, including OpenAI and Google .

---

## Part 5: The White House Strategy – A "Compromise" That Excludes the Pentagon

### The Path Forward

The April 17 meeting was, according to officials briefed on the matter, a "potential first step to a deal" . If a compromise is reached, it would likely exclude the Pentagon—at least initially.

Two officials told the New York Times that any agreement would probably involve other federal agencies, such as the Treasury Department and CISA, but would leave the Defense Department out . This would allow the administration to access Mythos for critical functions like financial system protection while continuing to litigate the military dispute.

### The "Counterproductive" Argument

Some White House officials have argued that the fight with Anthropic is "counterproductive" and denies the United States some of the most powerful tech tools available . With Mythos capable of identifying vulnerabilities that no other AI can find, the cost of exclusion is simply too high.

One Trump advisor told Axios: "This is a big deal. Everyone was complaining, and the circus was going on. So it got escalated to Susie's level for her to hear Dario out, sort out what was nonsense, and map out a path forward" .

### The Bessent Factor

Treasury Secretary Bessent's involvement is the clearest signal that the administration is serious about reaching a deal. A source familiar with his thinking said Bessent attended the meeting because "he wants to make sure everyone is on the same page" .

"He understands Anthropic is a private company, but the government has a role to play in this space," the source added .

---

## Part 6: The Global Context – The AI Arms Race Intensifies

### The UK and EU Response

The Mythos model has attracted attention far beyond Washington. The U.K.'s AI Security Institute conducted its own evaluation and found the model to be a "step up" over previous models .

Anthropic has also been in talks with the European Union about its AI models, including advanced models that haven't yet been released in Europe .

### The Chinese Threat

The "China gift" argument is not just rhetoric. As Jack Clark noted, within a year to 18 months, open-weight models from China will likely have capabilities similar to Mythos . If the U.S. government refuses to use its own technology, it will be ceding a critical advantage to its primary strategic competitor.

### The Banking Industry Vulnerability

The financial industry is particularly vulnerable to Mythos-style attacks. TJ Marlin, CEO of enterprise AI security firm Guardrail Technologies, warned that banks run technology stacks that integrate state-of-the-art tools with decades-old software, "potentially opening a large number of vulnerabilities" .

This is why Bessent—whose Treasury Department oversees the financial system—is so deeply involved.

---

## Part 7: The American Citizen’s Takeaway – What This Means for You

### For Your Financial Security

The White House-Anthropic meeting is about protecting the financial system. If Mythos can find vulnerabilities in banking infrastructure, and if the government can use it to patch those vulnerabilities before attackers find them, your money is safer.

### For Your Privacy

The dispute between Anthropic and the Pentagon centered on two red lines: no autonomous weapons and no mass domestic surveillance. Anthropic has held firm on these principles. The outcome of the negotiations will determine whether those guardrails survive.

### For U.S. Competitiveness

The "China gift" argument is real. If the U.S. government refuses to use its most advanced AI, it will fall behind in the global AI arms race. The White House appears to have recognized this—hence the rapid shift from "radical left" to "productive and constructive."

---

### FREQUENTLY ASKED QUESTIONS (FAQs)

**Q1: What did the White House and Anthropic agree on?**

A: No formal agreement was announced. The meeting was described as "introductory" and "productive," with both sides agreeing to continue the dialogue . The goal is to find a path forward that excludes the Pentagon while allowing other agencies to access Mythos.

**Q2: Why was the meeting called?**

A: The meeting was called because Mythos is too powerful for the government to ignore . Officials believe it is critical to access the model to protect government networks from cyberattacks .

**Q3: What is Claude Mythos Preview?**

A: It's Anthropic's latest AI model, capable of identifying and exploiting cybersecurity vulnerabilities. The company has deemed it too dangerous for public release .

**Q4: How powerful is Mythos?**

A: In tests by the U.K. AI Security Institute, Mythos succeeded in expert-level hacking tasks 73 percent of the time . Prior to April 2025, no AI model could complete those tasks at all.

**Q5: What is Project Glasswing?**

A: A $100 million defensive coalition of tech giants—including Amazon, Apple, Google, Microsoft, and JPMorgan Chase—using restricted access to Mythos to find and fix vulnerabilities .

**Q6: Why was the Pentagon fighting with Anthropic?**

A: Anthropic refused to grant the Pentagon "unrestricted" access to its AI, seeking assurances that it would not be used for autonomous weapons or mass domestic surveillance. The Pentagon declared that no private contractor could tell it how to use the technology .

**Q7: What is a "supply chain risk" designation?**

A: A label previously reserved for foreign adversaries like China's Huawei. The Pentagon applied it to Anthropic in March 2026, marking the first time a U.S. company had received the designation .

**Q8: What's the single biggest takeaway from the White House-Anthropic meeting?**

A: The meeting signals that the U.S. government cannot afford to be without Anthropic's technology. Despite months of bitter conflict, the power of Mythos has forced a détente. The question now is whether the two sides can reach a deal—and whether the Pentagon will be part of it.

---

## Conclusion: The Mythos Imperative

On April 17, 2026, the White House and Anthropic sat down at the same table for the first time in months. The numbers tell the story of a technology that has forced a reluctant administration to the negotiating table:

- **73%** – Mythos's success rate in hacking tasks

- **99%** – The share of vulnerabilities it found that remain unpatched

- **12** – The number of tech giants in Project Glasswing

- **$100 million** – The size of the defensive coalition

- **"Productive and constructive"** – The official White House description

For the officials who have been fighting to keep Anthropic out of the government, the meeting is a retreat. For the engineers who have been petitioning to keep using the technology, it is vindication. For the global AI race, it is a signal that the United States is finally taking the threat seriously.

The age of treating AI safety as a "radical left" issue is over. The age of **strategic AI partnership** has begun. And Dario Amodei, the CEO of a company that was publicly blacklisted just weeks ago, is now sitting in the West Wing.